Skip to main content
SpringerLink
Log in

Nicotine-Dependent Psychiatric Patients

  • Chapter
The Clinical Management of Nicotine Dependence

Abstract

The treatment of psychiatric disorders requires a constant awareness of the various factors that affect outcomes in both a negative and a positive manner. For example, we know that the social support derived from friends, spouse, or other family members is an unquestionable positive factor in not only improving but also in maintaining optimal mental health. However, schizophrenic patients do better in a low-emotional-expression setting in which family members minimize the amount of feelings expressed toward the schizophrenic member.1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vaughn CE, Leff JP. The influence of family and social factors on the course of psychiatric illness. Brit J of Psychi 1976; 129: 125–137.

    Article  CAS  Google Scholar 

  2. Dackis CA, Gold MS. Depression in drug abusers. Washington DC: American Psychiatric Press, 1984: 20–39.

    Google Scholar 

  3. Kosten TR. Pharmacotherapeutic interventions for cocaine abuse. J of Nerv and Mental Disease 1980; 177(7): 379–389.

    Article  Google Scholar 

  4. Kosten TR, Schumann B, Wright D, et al. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J of Clin Psychi 1987; 48(1): 442–444.

    CAS  Google Scholar 

  5. Kleber HD, Weissman MM, Roundsaville BJ, et al. Imipramine as treatment for depression in addicts. Arch of Gen Psychi 1983; 40: 649–653.

    CAS  Google Scholar 

  6. Cocores, JA. Treatment of the dually diagnosed adult drug user. In: Gold MS. Slaby AE, eds, Dual diagnosis patients. New York: Marcel Dekker, 1990.

    Google Scholar 

  7. Hughes JR, Hatsukami DK, Mitchell JE, et al. Prevalence of smoking among psychiatric outpatients. Am J of Psychi 1986; 143: 993–997.

    CAS  Google Scholar 

  8. O’Farrell TJ, Connors GJ, Upper D. Addictive behaviors among hospitalized psychiatric patients. Addict Behav 1983; 8: 329–333.

    Article  PubMed  Google Scholar 

  9. Cocores, JA. The 8OO-COCAINE book of drug and alcohol recovery. New York: Villard Books, 1990.

    Google Scholar 

  10. U.S. Department of Health and Human Services. Nicotine: Pharmacokinetics, metabolism, and pharmacodynamics. In: Nicotine addiction—a report of the Surgeon General. Washington, DC: U.S. Government Printing Office, 1988.

    Google Scholar 

  11. Benowitz NL. Pharmacologic agents of cigarette smoking and nicotine addiction. New Engl J of Med 1988; 319(20): 1318–1330.

    Article  CAS  Google Scholar 

  12. Fuxe K, Andersson K, Eneroth P, et al. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications. Psychoneuroendocrinology 1989; 13(192): 19–41.

    Article  Google Scholar 

  13. Pomerleau OF, Rosecrans J. Neuroregulatory effects of nicotine. Psychoneuroendocrinology 1989; 14(6): 407–423.

    Article  PubMed  CAS  Google Scholar 

  14. Pomerleau O. The effects of nicotine on brain neurotransmitter systems. In Balfour DJK, ed. Nicotine and the tobacco smoking habit. Oxford: Pregamon Press, 1984.

    Google Scholar 

  15. Wesnes K, Warborten DM. Smoking, nicotine and human performance. Pharmacol Therapeutics 1983; 21: 189–208.

    Article  CAS  Google Scholar 

  16. Pomerleau O. Nicotine as a psychoactive drug: Anxiety and pain reduction. Psychopharmacol Bull 1979; 22(3): 865–869.

    Google Scholar 

  17. Gilbert D. Paradoxical tranquilizing and emotion—Reducing effects of nicotine. Psychol Bull 1979; 86(4): 643–661.

    Article  PubMed  CAS  Google Scholar 

  18. Keenan RM, Hatsukami DK, Anton DJ. The effects of short term smokeless tobacco deprivation on performance. Psychopharmacology 1989; 98: 126–130.

    Article  PubMed  CAS  Google Scholar 

  19. Ague C. Nicotine and smoking: Effects upon subjective changes in mood. Psychopharmacologia 1973; 30: 323–328.

    Article  Google Scholar 

  20. Pomerleau OF, Turk DC, Fertig JB. The effects of cigarette smoking on pain and anxiety. Addict Behav 1984; 9: 265–271.

    Article  PubMed  CAS  Google Scholar 

  21. Miller RR. Effects of smoking on drug action. Clin Pharmacol and Therapeutics 1987; 22(5): 749–756.

    Google Scholar 

  22. Swett C. Drowsiness due to chlorpromazine in relation to cigarette smoking. Arch of Gen Psychi 1974; 31: 211–213.

    Google Scholar 

  23. Dawson GW, Jusko WJ. Smoking and drug metabolism. In: Balfour DJK, ed. Nicotine and the Tobacco smoking habit Oxford: Pregamon Press. 1984.

    Google Scholar 

  24. Gold MS. The good news about depression. New York: Villard Books, 1987.

    Google Scholar 

  25. Gold MS. The good news about panic, anxiety and phobias. New York: Villard Books, 1989.

    Google Scholar 

  26. Glassman AH, Stetner F, Walsh T, et al. Heavy smokers, smoking cessation, and clonidine. JAMA 1988; 259: 2863–2866.

    Article  PubMed  CAS  Google Scholar 

  27. Gold MS, Redmond DE, Kleber HD. Clonidine in opiate withdrawal. Lancet 1978; 1: 929.

    Article  PubMed  CAS  Google Scholar 

  28. Edwards NB, Simmons RC, Rosenthal TL, et al. Doxepin in the treatment of nicotine withdrawal. Psychosomatics 1988; 29(2): 203–206.

    PubMed  CAS  Google Scholar 

  29. Dilsaver SC, Majchrzak MJ, Alessi NE. Chronic treatment with amitriptyline produces supersensitivity to nicotine. Biol Psychi 1988; 23: 169–175.

    Article  CAS  Google Scholar 

  30. Hughes JR. Clonidine, depression, and smoking cessation. JAMA 1988; 259(19); 2901–2902.

    Article  Google Scholar 

  31. Churchill CM, Pariser SF, Larson CN, et al. Antidepressants and cessation of smoking. Am J of Psychi 1989; 146(9): 1238.

    CAS  Google Scholar 

  32. Cocores JA, Patel MD, Gold MS, Pottash AC. Cocaine abuse, attention deficit disorder, and bipolar disorder. J of Nerv Mental Disease 1987; 175(7): 431–432.

    Article  CAS  Google Scholar 

  33. Cocores JA, Davies RK, Mueller PS, Gold MS. Cocaine abuse and adult attention deficit disorder, J of Clin Psychi 1987; 48(9): 376–377.

    CAS  Google Scholar 

  34. Wender PH, Reimherr FW. Bupropion treatment of attention-deficit hyperactivity in adults. Am J of Psychi, 1990; 147(8): 1018–1020.

    CAS  Google Scholar 

  35. Barclay L, Kheyfets S. Tobacco use in Alzheimer’s disease. Clin Psychi News 1988; 16(12): 9.

    Google Scholar 

  36. Newhouse PA, Sunderland T, Tariot PN, et al. Intravenous nicotine in Alzheimer’s disease: A pilot study. Psychopharmacology 1988; 95: 171–175.

    Article  PubMed  CAS  Google Scholar 

  37. Hall GH. The pharmacology of tobacco smoking in relation to schizophrenia. In: Hemmings G, ed. Biochemistry of schizophrenia and addiction. Baltimore: University Park Press, 1980.

    Google Scholar 

  38. Sanberg PR, Fogelson HM, Manderscheid PZ, et al. Nicotine gum and haloperidol in Tourette’s syndrome. Lancet 1988; 95: 592.

    Article  Google Scholar 

  39. Yassa R, Samarthji L, Korpassy A, et al. Nicotine exposure and tardive dyskinesia. Biol Psychi 1987; 22: 67–72.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Wanda Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James A. Cocores
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark S. Gold
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Outpatient Recovery Centers, Fair Oaks Hospital, 07901, Summit, NJ, USA

    James A. Cocores M.D. (Medical Director) (Medical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Taylor, W., Cocores, J.A., Gold, M.S. (1991). Nicotine-Dependent Psychiatric Patients. In: Cocores, J.A. (eds) The Clinical Management of Nicotine Dependence. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9112-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-9112-8_24

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-9114-2

  • Online ISBN: 978-1-4613-9112-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation